Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2026 10:00 ET | Source: Ophirex

Ophirex Publishes Data from Phase 2 BRAVIO Trial Evaluating Intravenous Followed by Oral Varespladib for Snakebite

Publication of results from the Phase 2 BRAVIO clinical trial evaluating intravenous followed by oral varespladib for snakebite.
February 24, 2026 08:00 ET | Source: Ophirex

Ophirex to Supply Marimastat Drug Substance to Liverpool School of Tropical Medicine for Novel Snakebite Treatment Research

Ophirex will supply marimastat to Liverpool School of Tropical Medicine's Centre for Snakebite Research & Interventions’ (CSRI) Ph2 TOCSINS clinical trial.
December 11, 2025 08:00 ET | Source: Ophirex

Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment

Ophirex announces regulatory and business developments as it continues to advance varespladib as the first oral rescue treatment for snakebite.